ASCO 2025 Unveils Major Advances in Cancer Research and Treatment
TL;DR
At the ASCO cancer conference, groundbreaking research revealed that personalized exercise routines can outperform chemotherapy in preventing colon cancer recurrence, and AstraZeneca showcased promising early-stage immunotherapy treatments that could revolutionize cancer care by boosting survival rates and reducing side effects.
- 2 major cancer breakthroughs just dropped, and doctors are buzzing Business Insider
- Key takeaways from world’s largest cancer conference in Chicago The Guardian
- Inside ASCO 2025: Big data drops and a towering campaign Fierce Pharma
- American Society of Clinical Oncology, May 31-June 3 Physician's Weekly
- ASCO 2025: Key Highlights in Endometrial and Related Cancers Medscape
Want the full story? Read the original reporting
Read on Business Insider